Biomarkers
The bioanalytical services group of ICON Development Solutions supports the development and analysis of a broad range of biomarker assays across many therapeutic areas.
Related Information
Related News
- ICON Strengthens Global Scientific Council with the Appointments of Professor Brendan Buckley and Dr. Nicholas Alp »
- ICON Selected by Shire plc’s Specialty Pharmaceuticals division as Global Strategic Partner for Clinical Research and Central Laboratory Services »
- ICON PLC and Empire Genomics Partner for the Delivery of Personalised Medicine Services »
- ICON and Fountain Medical Development (FMD) Announce Opening of Laboratory Facility in China »
With close links to our in-vivo clinical pharmacodynamics group, we can provide a full suite of clinical and analytical biomarker services to support our clients’ development efforts.
Click here to learn more about ICON’s full suite of Biomarker capabilities.